Interferon adjuvant therapy of melanoma [3]

Cancer

Volumn 79, Issue 9, 1997, Pages 1843-1845

  Kirkwood, J M ^a   Wazer, D ^a   Rosenstein, M ^a   Nathanson, L ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON;

CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL TRIAL; DRUG EFFICACY; HIGH RISK PATIENT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LETTER; LYMPH NODE METASTASIS; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL TIME;

EID: 0030944184     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970501)79:9<1843::AID-CNCR33>3.0.CO;2-W     Document Type: Letter

References (3)